Jessica Calviello

Jessica Calviello

Auto-generated profile, based on publicly available information

Jessica Calviello

Metabolic Dynamics in Cancer Laboratory, Department of Cell Biology, Physiology and Immunology, School of Biology, Universitat de Barcelona (UB), Parc Científic de Barcelona; 08028 Barcelona, Spain

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JCJessica Calviello
Jessica Calviello
LPLisa Pöltl
Lisa Pöltl
AMAlessia Mira
Alessia Mira
FSFilippo Spini
Filippo Spini
ALAinhoa Larrañaga
Ainhoa Larrañaga
CMCarlos Sebastián Muñox
Carlos Sebastián Muñox
Tumor heterogeneity is a major determinant of tumor progression and therapeutic resistance, yet the contribution of metabolism to intratumoral heterogeneity still remains poorly explored. Here, we find that pyruvate dehydrogenase kinase-1 (Pdk1) expression defines metabolically distinct cancer cell populations in colorectal tumors. Image-based spatial single-cell phenotyping shows that Pdk1 high cells are associated with tumor progression in orthotopic models of colorectal cancer (CRC). Genetic ablation experiments demonstrate the role of Pdk1 high cells in tumor growth, 5-fluorouracil chemoresistance and tumor relapse. Mechanistically, we identify a link between Pdk1-driven metabolic states and specific cell phenotypes, where Pdk1 high cancer cells exhibit an EMT, stem cell-like phenotype characterized by increased interferon (IFN) signaling. Mitochondrial remodeling in Pdk1 high cells leads to the release of mitochondrial DNA to the cytosol and activation of IFN pathways, promoting Pdk1-driven phenotypes. Inhibition of IFN signaling impairs the tumorigenic and aggressive features of Pdk1 high cancer cells, thus establishing a functional connection between metabolic heterogeneity, cell-intrinsic IFN signaling and aggressive CRC.